Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Prostate. 2010 Jan 1;70(1):27–36. doi: 10.1002/pros.21035

Figure One. Anti-proliferative effects of F-4 in prostate cancer cell lines.

Figure One

LNCaP (top panels A–C) and PC-3 cells (bottom panels D–F) were treated with F-4, 17-AAG, or novobiocin for 24(▼), 48(♦) and 72(●) hours. Bioreduction of tetrazolium (MTS) dye to a formazan by-product was used to measure cellular proliferation. Combined normalized data from independent experiments is shown for cells treated with F-4 (panels A and D), 17-AAG (panels B and E), and novobiocin (panels C and F). Data was analyzed from 2–4 independent experiments performed in duplicate; each data point represents the mean ± SEM.